When exactly should I inject insulin lispro?

Inject 0-15 minutes before starting to eat, or immediately after you begin eating if meal composition is uncertain. Because lispro acts within 15 minutes, injecting it well before a meal (like regular insulin requires) is not necessary and can increase hypoglycemia risk if the meal is delayed. Never inject and then wait — eat promptly after injecting.

What is a correction dose and how do I use it?

A correction dose is extra insulin taken to bring a high pre-meal glucose back toward target. Your correction factor (insulin sensitivity factor) tells you how many mg/dL one unit of insulin will lower your glucose. For example, if your correction factor is 50 and your pre-meal glucose is 200 (target 120), you need (200-120)/50 = 1.6 units extra. Your diabetes care team will help you determine your correction factor.

Can I use insulin lispro in an insulin pump?

Yes. Insulin lispro is approved for use in continuous subcutaneous insulin infusion (CSII) pumps as the basal and bolus delivery. Pump therapy can provide superior glucose control with more flexibility than multiple daily injections for motivated patients. Discuss pump candidacy with your diabetes care team.

How does insulin lispro differ from regular insulin?

Insulin lispro (rapid-acting) begins working in 15 minutes, peaks in 1-2 hours, and lasts 3-4 hours. Regular insulin (short-acting) takes 30-60 minutes to start, peaks at 2-4 hours, and lasts 5-8 hours. This means regular insulin must be taken 30-45 minutes before eating, while lispro can be taken immediately before or even after a meal begins — a major convenience and safety advantage.

What to Expect When Starting Insulin lispro

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.

Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.

Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.

See our Terms of Use and Editorial Policy.

Introduction

Insulin lispro (Humalog, Admelog) is a rapid-acting insulin analog used to control blood sugar spikes at mealtimes in both type 1 and type 2 diabetes. It begins working within 15 minutes, peaks at 1-2 hours, and lasts 3-4 hours. Because it acts faster than regular insulin, it should be injected just before eating (or shortly after starting a meal). It is almost always used in combination with a long-acting basal insulin.

Week-by-week timeline

Day 1-3

Learning Mealtime Insulin

Insulin lispro is injected 0-15 minutes before a meal or immediately after starting a meal if meal size is uncertain. Inject subcutaneously in the abdomen (fastest absorption), thigh (intermediate), or upper arm. The dose is adjusted based on carbohydrate content of the meal (carb ratio) and correction factor for elevated pre-meal glucose.

Week 1-2

Dose Learning and Adjustment

Establishing the correct carbohydrate-to-insulin ratio and correction factor requires monitoring pre-meal and 2-hour post-meal blood glucose. Post-meal glucose should be within 30-50 mg/dL of pre-meal glucose at 2 hours. Your diabetes care team will help you adjust ratios.

Week 2-4

Pattern Recognition

Tracking meals, doses, and glucose readings reveals patterns — certain meals may consistently require dose adjustments. For type 2 diabetes patients, a simpler fixed dose at meals may be used initially rather than carb counting. Record glucose logs to share with your prescriber.

Month 1

Establishing Glucose Control

With basal and mealtime insulin working together, overall glucose control improves measurably. HbA1c reflects the previous 3 months of glucose control. Post-meal glucose spikes should be significantly reduced.

Month 2-3

Optimized Regimen

A well-titrated basal-bolus insulin regimen provides excellent glucose control for most patients with type 1 or 2 diabetes who need insulin. Continuous glucose monitoring (CGM) can enhance safety and time-in-range tracking significantly.

When to call your doctor

Contact your healthcare provider if you experience:

Severe hypoglycemia: unconsciousness, seizures, or inability to treat — call 911 and use glucagon if available
Rapid or unexpected hypoglycemia after a delayed or skipped meal (inject insulin lispro at the start of eating — not before uncertain meals)
Injection site infection: redness, warmth, pus
Diabetic ketoacidosis symptoms (especially type 1): nausea, vomiting, fruity breath, rapid breathing, extreme thirst
Severe or rapidly rising blood glucose despite insulin doses
Prolonged hypoglycemia that does not respond to 2 treatment cycles

Tips for getting started

Time your injection of insulin lispro carefully — take it at the start of the meal, not 30 minutes before (as with regular insulin). If you are unsure how much you will eat, inject after you have eaten to dose based on actual intake. Rotate injection sites and avoid areas of lipohypertrophy (lumpy tissue). Refrigerate unused vials or pens (36-46°F); room temperature is acceptable for up to 28 days after opening. Never shake insulin — roll the pen gently if mixing is needed. Always carry fast-acting glucose (glucose tablets, juice) for hypoglycemia. Check blood glucose before driving and treat if below 90 mg/dL.

Frequently asked questions

More about Insulin lispro

Insulin lispro drug guideSide effects, dosage, interactions, and more Insulin glargine vs Insulin lisproCompare these medications Metformin & Insulin lisproInteraction details

References

[Regulatory] FDA Label: Humalog (insulin lispro) Injection https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020563s115lbl.pdf Accessed 2026-03-01.
[Regulatory] NIH MedlinePlus: Insulin Lispro Injection https://medlineplus.gov/druginfo/meds/a697021.html Accessed 2026-03-01.
[Regulatory] ADA Standards of Care: Mealtime Insulin https://diabetesjournals.org/care/issue/47/Supplement_1 Accessed 2026-03-01.

Written and fact-checked by PrescriptionDrugs.org Editorial Team

Last updated: March 1, 2026